Back
ESC Premium Access

The risks and benefits of spironolactone use in heart failure with a reduced left ventricular ejection fraction and chronic kidney disease

Session: Chronic heart failure e-posters
Topic: Pharmacotherapy
Speaker: Mrs O. Obertynska (Vinnitsa, UA)
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

Like

About the speaker

Mrs Oksana Obertynska

National Pirogov Memorial Medical University, Vinnitsa (Ukraine)
0 follower

218 more presentations in this session

Intermittent therapy with levosimendan in patients with advanced heart failure

Speaker: Professor M. Weis (Munich, DE)

Access
Abstract
Slides
Like
Thumbnail

Differences in long-term all-cause and cardiovascular mortality according to heart failure aetiology in ambulatory patients

Speaker: Doctor G. Spitaleri (Sant Joan Despi (Barcelona), ES)

Access
Abstract
Slides
Like
Thumbnail

Comparing the central arterial stiffness indices in the decompensated and compensated states of heart failure: a cohort study

Speaker: Assistant Professor G. Youssef (Cairo, EG)

Access
Abstract
Slides
Like
Thumbnail

Opportunities for clinician education in the pharmacotherapy of stable heart failure

Speaker: Doctor P. Murray (Dublin, IE)

Access
Abstract
Slides
Like
Thumbnail

Systolic blood pressure visit-to-visit variability and clinical outcomes of heart failure with preserved ejection fraction

Speaker: Doctor Q. Zhang (Tianjin, CN)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Chronic heart failure e-posters

Speakers: Mrs O. Obertynska, Professor M. Weis, Doctor G. Spitaleri, Assistant Professor G. Youssef, Doctor P. Murray...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources